Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SuRage-EB: Local Treatment of Metastases in Melanoma Patients on Encorafenib + Binimetinib
NCT07092410Phase 4Withdrawn
- Start
- Aug 2025
- Primary completion
- Aug 2030
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of encorafenib, binimetinib in melanoma. Planned start Aug 2025; status: withdrawn.
02
Drugs
encorafenibbinimetinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT07092410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07092410.